What do the randomized controlled trials for Ivermectin for early outpatient treatment show? By Dr. Pierre Kory

Dr. Kory speaks in Senate Homeland Committee December 2020.

‘A Guide to Home-based COVID treatment’ here:
http://www.CovidPatientGuide.com

Who is Dr. Kory?
Dr. Kory is a lung and ICU specialist who currently serves as the President and Chief Medical Officer of the Front Line COVID-19 Critical Care Alliance. Considered one of the world’s clinical experts on ivermectin and COVID-19, he has co-authored ten manuscripts during the pandemic to date.

On December 8, 2020, Dr. Kory testified to the US Senate Committee on Homeland Security & Governmental Affairs on the urgency and importance of expediting the federal government review of low cost, widely available and potentially beneficial early combination treatments for COVID-19. Previously, Dr. Kory had testified May 6th, 2020 to Senate Committee regarding the timely role of corticosteroids in the treatment of COVID. Prior to COVID, Dr. Kory was considered a pioneer and international expert in both therapeutic hypothermia and critical care ultrasound. He served as the senior editor of a best-selling and award-winning ultrasound textbook which is now in its 2nd edition and seventh language translation. Dr. Kory is also considered a master educator and has won major departmental teaching awards at multiple institutions in his career.